EKSO

#4430
Ekso Bionics Holdings, Inc. Common Stock
11.6100 USD
+2.11%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
11.0400
11.6150
Range Annuel
7.8900
13.5000
Changement quotidien
+2.11%
Changement Mensuel
+15.98%
Evolution sur 6 mois
-7.27%
Changement Annuel
-7.27%
Clôture Précédente
11.3700
Ouvrir
11.4400
Plus Bas
11.0400
High
11.6150
Volume
18
Afficher le graphique complet

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 41.3709 M
  • Employee 55
  • Founded 2005
  • CEO Scott Davis
  • Website www.eksobionics.com
  • Headquarter Nevada, United States
  • FIGI BBG002Z0NKK4
  • Industry Instruments et Fournitures Médicales
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.76
ratio cours/chiffre d'affaires
1.64

Ekso Bionics Holdings Inc

Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk. Ekso Bionics currently focuses in the health and industrial sectors. The company's first commercially available health product was called EksoGT. Ekso Bionics is the original developer of HULC, now under military development by Lockheed Martin, and the current developers of EksoNR, which allows patients who are relearning to walk the ability to stand and take steps. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community.

Nouvelles